Infertility. Inflammatory diseases of female pelvic organs
Conditions
Interventions
Intervention 1: group I: clomiphen citrate 50 mg twice a day from 3th day of menstruation cycle until 7th day of the cycle. Intervention 2: group II: letrozole 2.5 mg twice a day from 3th of the cyc
Sponsors
shahid sadoughi university of medical science
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: three or fewer oocytes were been retrieved in previous failed ART cycle; serum E2 levels = 500 pg/ml on the day of hCG administration.
Exclusion criteria
Exclusion criteria: BMI >30 mg/m2; endocrine or metabolic disorders; history of ovarian surgery; severe endometriosis; azoospermia in male partner. FSH >15 m IU/ml
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 12 day after embryo transfer. Method of measurement: beta hCG blood test.;Clinical pregnancy. Timepoint: 3 weeks after chemical pregnancy. Method of measurement: observation of fetal heart activity by transvaginal ultrasonography.;Implantation rate. Timepoint: 3 weeks after chemical pregnancy. Method of measurement: the ratio of the number of embryonic sacs diagnosed by sonography to the total number of the embryos transferred. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Eftekhar
Research and Clinical Center for Infertility
Outcome results
None listed